Intercept Stock Rockets on Earnings, Positive Drug Results

Shares of Intercept Pharmaceuticals Inc. (ICPT) were up +137.82 or +58.11 percent to $375.00 per share in pre-market trading on Tuesday, after the company announced better than expected earnings late yesterday. The company also disclosed its obeticholic acid had less severe side effects and was more effective in treating liver disease than what was previously Read the full article... Read the rest of Intercept Stock Rockets on Earnings, Positive Drug Results at InvestorGuide.com .